Skip to content

Over-the-counter sales of an erectile dysfunction medication get the green light in Japan

Japan's health ministry's expert panel authorizes sale of certain pharmaceuticals without prescription on Thursday.

Approval Granted for Over-the-Counter Sale of Erectile Dysfunction Medicine in Japan
Approval Granted for Over-the-Counter Sale of Erectile Dysfunction Medicine in Japan

Over-the-counter sales of an erectile dysfunction medication get the green light in Japan

The Japanese Health Minister has announced that public comments will be gathered before making a decision on the over-the-counter (OTC) sale of Cialis, a popular treatment for erectile dysfunction. If approved, Cialis would become the second erectile dysfunction treatment available for OTC purchase in Japan, following Viagra.

SSP Co., a Tokyo-based drug manufacturer, has acquired a license for Cialis from Nippon Shinyaku Co., a Kyoto-based drugmaker, for the purpose of seeking OTC sales approval from the Japanese health ministry. The license for Cialis was originally held by Nippon Shinyaku Co.

SSP Co. has filed for the health ministry's approval for the OTC sales of Cialis, and the Japanese Health Minister's expert panel has already given their approval for the OTC sales of a drug for treating erectile dysfunction.

If endorsed, Cialis will be available for purchase at drugstores in Japan with guidance from pharmacists. This move is expected to increase opportunities for erectile dysfunction treatment, as Cialis will be more accessible to those who currently have difficulty obtaining a prescription.

It's worth noting that erectile dysfunction is a significant factor in declining birthrates, according to SSP Co. If endorsed by the health minister, Cialis will be the first erectile dysfunction treatment available for OTC purchase in Japan.

Currently, Cialis is only available with a prescription from a doctor. The OTC sale of Cialis in Japan is still pending the health minister's endorsement after public comments are gathered.

In conclusion, the potential OTC sale of Cialis in Japan is an important step towards increasing accessibility to erectile dysfunction treatments and potentially addressing the issue of declining birthrates. We will continue to follow this story as it develops.

Read also:

Latest